Mary DiBiase - 23 Jun 2023 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Signature
/s/ Adam S. Mostafa, attorney-in-fact
Issuer symbol
XFOR
Transactions as of
23 Jun 2023
Net transactions value
-$1,654
Form type
4
Filing time
26 Jun 2023, 16:15:35 UTC
Previous filing
16 Jun 2023
Next filing
05 Jul 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XFOR Common Stock Sale $1,654 -857 -0.56% $1.93 151,000 23 Jun 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $1.90 to $1.96, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 Of the shares of common stock reported, 84,624 shares represent restricted stock units.